摘要
Depression is a major global public health concern, affecting around 280 million people and contributing substantially to disability, mortality, and economic burden. Although psychotherapies are effective, their overall impact is limited. Many patients do not respond to treatment and access to care remains low worldwide, especially in low- and middle-income countries, but also in high-income countries. There are three basic strategies than can help with the reduction of the disease burden of depression at the population level: prevention, increasing treatment uptake, and improving treatment outcomes. (1) Prevention includes universal, selective, and indicated approaches, with the latter two showing potential to reduce incidence but are limited by targeting the right population and low uptake. Newer strategies like early-life interventions and indirect methods may enhance the overall impact of prevention on the disease burden at the population level. (2) Improving the uptake of evidence based treatments can be realized with anti-stigma campaigns, mental health literacy programs, the development of scalable digital interventions, task-sharing interventions, and for example single session interventions. (3) Much research is conducted on methods to increase the effects of treatment outcomes, including the development of innovative digital tools, such as Just-in-time-adaptive interventions, chatbots based on large language models, personalized therapies, relapse prevention, and psychedelic-assisted treatments. While some, like relapse prevention, are well-supported, others remain experimental. Overall, no single innovation is likely to dramatically transform outcomes. The most realistic way to further reduce the burden of disease is through gradual, incremental improvements across prevention, access, and treatment.